PAŘENICA, Jiří, Jiří JARKOVSKÝ, Jan MALÁSKA, Alexandre MEBAZAA, Jana GOTTWALDOVÁ, Kateřina HELÁNOVÁ, Jiří LITZMAN, Milan DASTYCH, Josef TOMANDL, Jindřich ŠPINAR, Ludmila DOSTÁLOVÁ, Petr LOKAJ, Marie TOMANDLOVÁ, Monika PÁVKOVÁ GOLDBERGOVÁ, Pavel ŠEVČÍK a Matthieu LEGRAND. Infectious complications and immune/inflammatory response in cardiogenic shock patients: A prospective observational study. Shock. Philadelphia: Lippincott Williams & Wilkins, 2017, roč. 47, č. 2, s. 165-174. ISSN 1073-2322. Dostupné z: https://dx.doi.org/10.1097/SHK.0000000000000756.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Infectious complications and immune/inflammatory response in cardiogenic shock patients: A prospective observational study
Autoři PAŘENICA, Jiří (203 Česká republika, garant, domácí), Jiří JARKOVSKÝ (203 Česká republika, domácí), Jan MALÁSKA (203 Česká republika, domácí), Alexandre MEBAZAA (250 Francie), Jana GOTTWALDOVÁ (203 Česká republika, domácí), Kateřina HELÁNOVÁ (203 Česká republika), Jiří LITZMAN (203 Česká republika, domácí), Milan DASTYCH (203 Česká republika, domácí), Josef TOMANDL (203 Česká republika, domácí), Jindřich ŠPINAR (203 Česká republika, domácí), Ludmila DOSTÁLOVÁ (203 Česká republika, domácí), Petr LOKAJ (203 Česká republika, domácí), Marie TOMANDLOVÁ (203 Česká republika, domácí), Monika PÁVKOVÁ GOLDBERGOVÁ (203 Česká republika, domácí), Pavel ŠEVČÍK (203 Česká republika) a Matthieu LEGRAND (250 Francie).
Vydání Shock, Philadelphia, Lippincott Williams & Wilkins, 2017, 1073-2322.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30201 Cardiac and Cardiovascular systems
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 3.005
Kód RIV RIV/00216224:14110/17:00096765
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1097/SHK.0000000000000756
UT WoS 000392813300007
Klíčová slova anglicky Cardiogenic shock; C-reactive protein; infection; inflammatory response; pentraxin 3; presepsin; procalcitonin
Štítky EL OK
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Soňa Böhmová, učo 232884. Změněno: 8. 3. 2018 14:25.
Anotace
Introduction: Patients with cardiogenic shock (CS) are at a high risk of developing infectious complications; however, their early detection is difficult, mainly due to a frequently occurring noninfectious inflammatory response, which accompanies an extensivemyocardial infarction (MI) or a postcardiac arrest syndrome. The goal of our prospective study was to describe infectious complications in CS and the immune/inflammatory response based on a serial measurement of several blood-based inflammatory biomarkers. Methods: Eighty patients with CS were evaluated and their infections were monitored. Inflammatory markers (C-reactive protein, procalcitonin, pentraxin 3, presepsin) were measured seven times per week. The control groups consisted of 11 patients with ST segment elevation myocardial infarction without CS and without infection, and 22 patients in septic shock. Results: Infection was diagnosed in 46.3% of patients with CS; 16 patients developed an infection within 48 h. Respiratory infection was most common, occurring in 33 out of 37 patients. Infection was a significant or even the main reason of death only in 3.8% of all patients with CS, and we did not find statistically significant difference in 3-month mortality between group of patients with CS with and without infection. There was no statistically significant prolongation of the duration of mechanical ventilation associated with infection. Strong inflammatory response is often in patientswith CS due to MI, but we found no significant difference in the course of the inflammatory response expressed by evaluated biomarkers in patients with CS with and without infection. We found a strong relationship between the elevated inflammatory markers (sampled at 12 h) and the 3-month mortality: the area under the curve of receiver operating characteristic ranged between 0.683 and 0.875. Conclusion: The prevalence of infection in patients with CS was 46.3%, and respiratory tract infections were the most common type. Infections did not prolong statistically significantly the duration of mechanical ventilation and did not increase the prevalence of hospital mortality in this high-risk CS population. CS due to acute myocardial infarction was accompanied by a strong and highly variable inflammatory response, but it did not reach the intensity of the inflammatory response observed in patients with septic shock. An extensive immune/inflammatory response in patients with CS is linked to a poor prognosis.
Návaznosti
MUNI/A/1362/2015, interní kód MUNázev: Neurohumorální profil a prognóza pacientů s chronickým srdečním selháním
Investor: Masarykova univerzita, Neurohumorální profil a prognóza pacientů s chronickým srdečním selháním, DO R. 2020_Kategorie A - Specifický výzkum - Studentské výzkumné projekty
VytisknoutZobrazeno: 25. 4. 2024 13:09